ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Suppression of cytokine release syndrome during CAR-T-cell therapy via a subcutaneously injected interleukin-6-adsorbing hydrogel

Li, Xianlei; Gong, Ningqiang*; Tian, Falin; Zhang, Shangkun; Zhang, Yuxuan; Wang, Yufei; Qing, Guangchao; Wang, Yongchao; Li, Fangzhou; Xu, Yihui; Zhang, Linlin; Wang, Jinjin; Ni, Qiankun; Gan, Yaling; Gu, Chaojiang; Jiang, Huaidong; Huang, Xingxu; Shi, Xinghua; Zhang, Tongcun; Wu, Yan*; Liang, Xing-Jie*广州医学院; 国家纳米科学中心; 中国科学院研究生院; 中国科学院; y
Nature Biomedical Engineering2023-9DOI: 10.1038/s41551-023-01084-4
5被引4阅读
引用收藏
分享

摘要

The infusion of chimaeric antigen receptor (CAR) T cells can trigger the release of life-threatening supraphysiological levels of pro-inflammatory cytokines. However, uncertainty regarding the timing and severity of such cytokine release syndrome (CRS) demands careful monitoring of the conditions required for the administration of neutralizing antibodies. Here we show that a temperature-sensitive hydrogel conjugated with antibodies for the pro-inflammatory cytokine interleukin-6 (IL-6) and subcutaneously injected before the infusion of CAR-T cells substantially reduces the levels of IL-6 during CRS while maintaining the therapy's antitumour efficacy. In immunodeficient mice and in mice with transplanted human haematopoietic stem cells, the subcutaneous IL-6-adsorbing hydrogel largely suppressed CAR-T-cell-induced CRS, substantially improving the animals' survival and alleviating their levels of fever, hypotension and weight loss relative to the administration of free IL-6 antibodies. The implanted hydrogel, which can be easily removed with a syringe following a cooling-induced gel-sol transition, may allow for a shift in the management of CRS, from monitoring to prevention. @@@ A subcutaneously injected hydrogel conjugated with antibodies for interleukin-6 substantially reduces the levels of the cytokine during chimaeric antigen receptor T-cell therapy while maintaining its antitumour efficacy.

相关
加载中…
  • Successful treatment of severe cytokine release syndrome after CAR-T therapy by ruxolitinib without compromising CAR-T efficacy
    Gu, Chengyuan; Wu, Qian; Zhang, Jingren; Kang, Liqing; Yu, Lei; Qiu, Huiying; Wu, Depei; Chen, Suning; Yang, Xiaofei*LEUKEMIA & LYMPHOMA, 2023, 64(2): 495-498.被引 3
  • Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
    Xiao, Xinyi; Huang, Shengkang; Chen, Sifei; Wang, Yazhuo; Sun, Qihang; Xu, Xinjie*; Li, Yuhua*JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40(1): 367.被引 60
  • Promoting the Recruitment, Engagement, and Reinvigoration of Effector T Cells via an Injectable Hydrogel with a Supramolecular Binding Capability for Cancer Immunotherapy
    Zhu, Yueqiang; Jin, Liangjie; Chen, Junbin; Su, Miao; Sun, Tianmeng; Yang, Xianzhu*Advanced Materials, 2023.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Nature Biomedical Engineering
发表日期
2023-09
卷期
第 7 卷, 第 9 期
DOI
10.1038/s41551-023-01084-4
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2021YFA1201000]; National Natural Science Foundation of China (NSFC) key project [32030060, 81773185]; NSFC international collaboration key project [51861135103]; Chinese Academy of Sciences (CAS-NSTDA) International Partnership Program [121D11KYSB20210003]

作者

  • L

    Li, Xianlei (第一作者)

    cas · chinese acad sci · natl ctr nanosci & technol · univ chinese acad sci

  • G

    Gong, Ningqiang (通讯)

    cas · chinese acad sci · natl ctr nanosci & technol · univ chinese acad sci

查看全部 21 位作者收起作者
  • T

    Tian, Falin

    univ chinese acad sci · cas · natl ctr nanosci & technol

  • Z

    Zhang, Shangkun

    wuhan univ sci & technol

  • Z

    Zhang, Yuxuan

    cas · chinese acad sci · natl ctr nanosci & technol · univ chinese acad sci

  • W

    Wang, Yufei

    cas · chinese acad sci · natl ctr nanosci & technol · univ chinese acad sci

  • Q

    Qing, Guangchao

    cas · chinese acad sci · natl ctr nanosci & technol

  • W

    Wang, Yongchao

    cas · chinese acad sci · natl ctr nanosci & technol

  • L

    Li, Fangzhou

    cas · chinese acad sci · natl ctr nanosci & technol

  • X

    Xu, Yihui

    shanghaitech univ

  • Z

    Zhang, Linlin

    shanghaitech univ

  • W

    Wang, Jinjin

    cas · chinese acad sci · natl ctr nanosci & technol · univ chinese acad sci

  • N

    Ni, Qiankun

    cas · chinese acad sci · natl ctr nanosci & technol · univ chinese acad sci

  • G

    Gan, Yaling

    cas · chinese acad sci · natl ctr nanosci & technol

  • G

    Gu, Chaojiang

    wuhan univ sci & technol

  • J

    Jiang, Huaidong

    shanghaitech univ

  • H

    Huang, Xingxu

    shanghaitech univ

  • S

    Shi, Xinghua

    univ chinese acad sci · cas · natl ctr nanosci & technol

  • Z

    Zhang, Tongcun

    wuhan univ sci & technol

  • W

    Wu, Yan (通讯)

    cas · chinese acad sci · natl ctr nanosci & technol · univ chinese acad sci

  • L

    Liang, Xing-Jie (通讯)

    guangzhou med univ · cas · chinese acad sci · natl ctr nanosci & technol · univ chinese acad sci

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417